Shareholder Wei Xuening of Changchun Bcht Biotechnology Co., Ltd. (688276.SH) has reduced his holding by a total of 301,800 shares in the company.

15/01/2025

Baike Biological (688276.SH) issued a statement on January 15, 2025, stating that the company has received a letter from shareholder Wei Xueling...

Changchun Bcht Biotechnology (688276.SH) announced that on January 15, 2025, the company received a notice from shareholder Mr. Wei Xuening regarding the implementation results of the reduction plan. The reduction results are as follows: Mr. Wei Xuening reduced his holdings in the company by a total of 301,800 shares through centralized bidding trading, accounting for 0.0730% of the total share capital of the company. As of the disclosure date of this announcement, the time period for this reduction plan has been completed.

Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.

JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.

ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.

Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.

ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.